In:
Advances in Skin & Wound Care, Ovid Technologies (Wolters Kluwer Health), Vol. 34, No. 2 ( 2021-2), p. 109-111
Abstract:
Medication-induced ulcers are generally rare. Although the tyrosine kinase inhibitor imatinib mesylate is frequently prescribed, the occurrence of ulcers related to the medication has not been previously described. Herein, the authors report a case of a patient with impaired wound healing that was attributed to imatinib mesylate treatment. Providers should maintain suspicion for medication-induced ulcers, particularly if treatment for the presumed underlying cause of an ulcer fails.
Type of Medium:
Online Resource
ISSN:
1538-8654
,
1527-7941
DOI:
10.1097/01.ASW.0000725176.48771.0f
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2021
detail.hit.zdb_id:
2053383-4
Permalink
